scholarly journals Direct and indirect cost of urea excretion

1996 ◽  
Vol 49 (6) ◽  
pp. 1598-1607 ◽  
Author(s):  
Lise Bankir ◽  
Nadine Bouby ◽  
Marie-Marcelle Trinh-Trang-Tan ◽  
Mina Ahloulay ◽  
Dominique Promeneur
Keyword(s):  
Indirect Cost ◽  
Urea Excretion

scholarly journals THE RATE OF UREA EXCRETION

1923 ◽  
Vol 55 (2) ◽  
pp. 105-111
Author(s):  
T. Addis ◽  
D.R. Drury
Keyword(s):  
Urea Excretion

Resource use and costs associated with different states of breast cancer

2007 ◽  
Vol 23 (2) ◽  
pp. 223-231 ◽  
Author(s):  
Mathias Lidgren ◽  
Nils Wilking ◽  
Bengt Jönsson ◽  
Clas Rehnberg
Keyword(s):  
Breast Cancer ◽  
Indirect Cost ◽  
Informal Care ◽  
Resource Use ◽  
Primary Breast Cancer ◽  
Primary Diagnosis ◽  
Patient Questionnaire ◽  
First Year ◽  
Medical Resource ◽  
Total Cost

Objectives: This study investigated the direct medical resource use and cost, informal care cost, and indirect cost associated with breast cancer in different states of the disease in normal clinical practice.Methods: A retrospective database analysis was used to estimate direct medical resource use and cost, and a patient questionnaire was used to evaluate informal care and work capacity in different states of breast cancer.Results: For patients younger than 65 years of age, the first year after a primary diagnosis total cost amounted to 280,000 SEK ($39,000) and the first year after a local or contralateral recurrence total cost was 351,000 SEK ($48,900). The second and following years after primary breast cancer or recurrence had substantially lower total cost, amounting to 94,000 SEK ($13,000). For patients with metastatic disease, the annual total cost was estimated to 334,000 SEK ($46,500). For patients older than 65 years of age, the total cost for the first year after a primary diagnosis amounted to 80,000 SEK ($11,200) and the total cost for the first year after a local or contralateral recurrence was 92,000 SEK ($12,900). The total cost for the second and following years after primary breast cancer or recurrence was estimated to 18,000 SEK ($2,600), and the total annual cost for patients with metastatic was 122,000 SEK ($17,000).Conclusions: Both direct medical costs and indirect cost vary substantially between disease states. For patients under 65 year of age, indirect costs accounted for more than 50 percent of the total cost.

A survey of indirect cost estimating in practice

1994 ◽  
Vol 12 (1) ◽  
pp. 31-36 ◽  
Author(s):  
J. H. M. Tah ◽  
A. Thorpe ◽  
R. McCaffer
Keyword(s):  
Indirect Cost ◽  
Cost Estimating
Sign in / Sign up

Export Citation Format

Share Document